Carrera Capital Advisors Increases Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Carrera Capital Advisors increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 9.3% in the 4th quarter, Holdings Channel.com reports. The firm owned 553 shares of the healthcare conglomerate’s stock after acquiring an additional 47 shares during the quarter. Carrera Capital Advisors’ holdings in UnitedHealth Group were worth $280,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in UNH. AlphaMark Advisors LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth $30,000. RPg Family Wealth Advisory LLC acquired a new stake in shares of UnitedHealth Group during the third quarter worth about $37,000. DecisionPoint Financial LLC boosted its position in shares of UnitedHealth Group by 155.0% in the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after purchasing an additional 62 shares during the period. Legacy Investment Solutions LLC acquired a new position in UnitedHealth Group during the third quarter worth approximately $57,000. Finally, Tacita Capital Inc boosted its holdings in shares of UnitedHealth Group by 166.7% in the fourth quarter. Tacita Capital Inc now owns 112 shares of the healthcare conglomerate’s stock valued at $57,000 after acquiring an additional 70 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

UNH has been the subject of a number of recent research reports. Stephens increased their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research note on Thursday, December 5th. Cantor Fitzgerald reissued an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Truist Financial dropped their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Finally, Oppenheimer boosted their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. One research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of $629.32.

Insider Buying and Selling

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this link. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Stock Up 1.6 %

UNH opened at $474.58 on Wednesday. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a market cap of $436.74 billion, a price-to-earnings ratio of 30.62, a PEG ratio of 1.37 and a beta of 0.61. The business’s fifty day moving average is $515.18 and its two-hundred day moving average is $555.37. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter in the previous year, the business posted $5.83 earnings per share. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. Analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be given a $2.10 dividend. The ex-dividend date of this dividend is Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.77%. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.